TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

Charles River Beat Expectations But Why Is The Stock Falling?

Benzinga Logo Benzinga By Vandana Singh
Charles River Beat Expectations But Why Is The Stock Falling?

Charles River Laboratories reported Q3 2025 earnings beating expectations, with revenue of $1.01 billion, but lowered full-year guidance and announced strategic asset sales, causing stock to decline.

Insights
CRL   negative

Despite beating quarterly earnings expectations, the company lowered full-year revenue guidance, announced underperforming asset sales, and experienced an 8.12% stock price drop due to challenging market conditions